Sign in

CIK 0001737953

  • Non-accelerated filer
  • Smaller reporting company

Replimune Group, Inc.

Sign in to watch
Ticker
REPL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
Operating
EIN
822082553
Phone
+1 781-222-9600
Business address
500 UNICORN PARK, WOBURN, MA, 01801
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$521,860
in 2 filings

Net −$521,860. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Dhingra Kapil −$409K Director sold 50% of stake
  2. SLATTERY JOSEPH P −$113K Director sold 78% of stake

Reading 83 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-01-19 Esposito Pamela Chief Business Officer Option exercise · Employee Stock Option (right to buy) −5,727 73,203
2021-01-19 Astley-Sparke Philip Chief Executive Officer Sale −800 $43.15 $35K 1,262,929
2021-01-19 Astley-Sparke Philip Chief Executive Officer Sale −7,632 $42.40 $324K 1,255,297
2021-01-19 Esposito Pamela Chief Business Officer Option exercise +5,727 $1.01 $6K 181,721
2021-01-19 Esposito Pamela Chief Business Officer Sale −600 $43.24 $26K 181,121
2021-01-19 Esposito Pamela Chief Business Officer Sale −5,127 $42.38 $217K 175,994
2021-01-19 Esposito Pamela Chief Business Officer Option exercise · Employee Stock Option (right to buy) −5,727 73,203
2021-01-19 Love Colin Chief Operating Officer Sale −700 $43.25 $30K 953,681
2021-01-19 Love Colin Chief Operating Officer Sale −7,157 $42.38 $303K 946,524
2021-01-15 Esposito Pamela Chief Business Officer Option exercise +29,273 $1.01 $30K 205,267
2021-01-15 Esposito Pamela Chief Business Officer Sale −29,273 $43.58 $1.3M 175,994
2021-01-15 Esposito Pamela Chief Business Officer Option exercise · Employee Stock Option (right to buy) −29,273 78,930
2021-01-15 Astley-Sparke Philip Chief Executive Officer Sale −1,100 $44.95 $49K 1,279,197
2021-01-15 Astley-Sparke Philip Chief Executive Officer Sale −6,059 $43.71 $265K 1,273,138
2021-01-15 Astley-Sparke Philip Chief Executive Officer Sale −9,409 $43.02 $405K 1,263,729
2021-01-15 Esposito Pamela Chief Business Officer Option exercise +29,273 $1.01 $30K 205,267
2021-01-15 Esposito Pamela Chief Business Officer Sale −29,273 $43.58 $1.3M 175,994
2021-01-15 Esposito Pamela Chief Business Officer Option exercise · Employee Stock Option (right to buy) −29,273 78,930
2021-01-15 Love Colin Chief Operating Officer Sale −2,200 $45.01 $99K 974,324
2021-01-15 Love Colin Chief Operating Officer Sale −7,547 $43.80 $331K 966,777

Page 16 of 19 · 365 trades